ACADIA Pharmaceuticals Inc. news

   Watch this stock
Showing stories 1 - 10 of about 88   

Articles published

ACAD 38.17 +0.26 (0.69%)
price chart
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Price Target Update
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD): 7 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $47.71 in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). However, the stock price could fluctuate by $ 4.61 from ...
Cowen assigns $50 PT on ACADIA Pharmaceuticals Inc. (ACAD); MKM updates view ...  Markets Daily
Why Piper Jaffray Is Upgrading Acadia Pharmaceuticals After A 25% Decline  Benzinga
Trade-Ideas: ACADIA Pharmaceuticals (ACAD) Is Today's Post-Market Leader Stock
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.
Insights On Trending Biotech Stocks - Incyte Corporation (NASDAQ:INCY), ACADIA ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) rose 4.21% to finish last trading session at $37.91. The company, on August 6, 2015, declared its unaudited financial results for the second quarter ended June 30, 2015.
Why Sprouts Farmers Market Inc. (SFM), ACADIA Pharmaceuticals Inc. (ACAD) and ...
It could have been worse, though … and it was worse for owners of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Sprouts Farmers Market Inc. (NASDAQ:SFM) and Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), which all fell by double-digits on Friday, ...
Why ACADIA Pharmaceuticals Inc Jumped 17% in July  Motley Fool
Acadia Pharma May No Longer Be A Buy Ahead Of NDA Filing  Benzinga
ACADIA Pharmaceuticals Inc. Price Target Update
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD): The mean estimate for the short term price target for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands at $47.71 according to 7 Analysts. The higher price target estimate for the stock has been calculated ...
Acadia Pharmaceuticals (ACAD) Shares Cross Below 200 DMA  Nasdaq
Healthcare Sector Movers: ACADIA Pharmaceuticals Inc. (ACAD), Biocept, Inc ...  WallStreet Scope
Large Outflow of Money Witnessed in ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) managed to eke out gains of 0.31% in intraday trade. The share price increased by 0.11 points to $36.1.
Biotech Stocks that your portfolio will love: ACADIA Pharmaceuticals Inc ...
However, biotech stocks bucked the trend, continuing to make strong inroads. On the trading floor, shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) gained 1.61% to close at $34.14. The $3.30B company on August 6, 2015 announced the publication ...
HC Wainwright Maintains Buy on ACADIA Pharmaceuticals Inc. Following Meeting ...
In a research report issued yesterday, H.C. Wainwright analyst Andrew Fein maintained a Buy rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with a $50 price target, after having a meeting with management last week. Fein noted, “The main ...
ACADIA Pharmaceuticals's "Buy" Rating Reaffirmed at HC ...  Dakota Financial News
ACADIA Pharmaceuticals Rating Reiterated by HC Wainright (ACAD)  The Legacy
Today's Water-Logged And Getting Wetter Stock: ACADIA Pharmaceuticals (ACAD)
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.
Short Interest Update on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), According to the latest information the short interest in ACADIA Pharmaceuticals Inc. plummeted by 3.8% or 514,698 shares. The final shorts are 13.2% of the total floated shares. The positions dropped from ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported a loss  Inside Trade
Zacks Short Term Rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)  Insider Trading Report